TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/12/08 21:55 | 3/7/08 | PHRM | Pharmion Corp | Health | Drug | Pharmaceutical Preparations | Cosgrave Michael | CO | O | EVP,Glob | M.d | 272 | 72.49 | 0 | 4 | 0 | D | ||||||||||||||||
12/7/07 18:40 | 12/6/07 | PHRM | Pharmion Corp | Health | Drug | Pharmaceutical Preparations | Cosgrave Michael | CO | O | EVP,Glob | M.d | 80 | 63.98 | 0 | 1 | New | 1 | D | |||||||||||||||
8/15/07 15:39 | 8/14/07 | PHRM | Pharmion Corp | Health | Drug | Pharmaceutical Preparations | Cosgrave Michael | CO | O | EVP,Chie | M.d | 207 | 5.55 | 0 | 37 | 0 | D | ||||||||||||||||
8/15/07 15:39 | 8/14/07 | PHRM | Pharmion Corp | Health | Drug | Pharmaceutical Preparations | Cosgrave Michael | CO | O | EVP,Chie | S.d | -1,507 | 40.32 | 0 | -37 | -100 | 0 | D | |||||||||||||||
12/15/04 12:52 | 12/13/04 | PHRM | Pharmion Corp | Health | Drug | Pharmaceutical Preparations | Cosgrave Michael | CO | O | VP | M.d | 198 | 3.43 | 0 | 58 | 0 | D | ||||||||||||||||
12/15/04 12:52 | 12/13/04 | PHRM | Pharmion Corp | Health | Drug | Pharmaceutical Preparations | Cosgrave Michael | CO | O | VP | S.dm | -2,721 | 47.22 | 0 | -58 | -100 | 0 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |